Dogwood Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | |||
EBITDA | -4,968 | -3,748 | -15,728 |
EBIT | -4,985 | -15,746 | |
Net Income | -4,986 | -3,780 | -15,744 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -4,587 | -3,637 | -3,272 |
Cash | 13,227 | 6,524 | 10,126 |
Basic Shares | 33,544 | 14,521 | 1,919 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12 | |||
EBITDA | -34,034 | -12,245 | -5,296 | -12,247 |
EBIT | -34,036 | -12,258 | -5,446 | -12,315 |
Net Income | -34,257 | -12,349 | -5,296 | -12,247 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,618 | -8,790 | -4,870 | -11,467 |
Cash | 6,524 | 14,847 | 3,316 | 7,030 |
Basic Shares | 8,220 | 1,027 | 751 | 442 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.34 |
2026-03-31 | -$0.15 |
2025-12-31 | -$0.26 |
2025-09-30 | -$8.20 |